Financials
- Market Capitalization 3.68 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1540 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 8.28 USD | +1.35% | -0.72% | +101.95% | +279.82% | 3.75 B USD | ||
| 1543 | DNLI Denali Therapeutics Inc. - Common Stock | 23.27 USD | -2.06% | -5.98% | +1.84% | +43.91% | 3.72 B USD | ||
| 1587 | VCYT Veracyte, Inc. - Common Stock | 43.43 USD | +0.56% | -0.80% | -6.32% | +17.70% | 3.49 B USD | ||
| 1596 | ABCL AbCellera Biologics Inc. - Common Shares | 11.28 USD | -1.74% | -7.69% | +97.89% | +177.83% | 3.46 B USD |